飞秒LASIK联合加速交联与常规飞秒LASIK在高度近视眼中的前瞻性随机对照试验
该前瞻性随机对眼对照试验纳入26例高度近视患者,一眼行LASIK联合加速角膜交联(LASIK Xtra),另一眼行常规飞秒LASIK(convLASIK)。12个月随访显示两组在未矫正远视力、屈光稳定性和角膜地形图稳定性上无显著差异,LASIK Xtra未显示出优于常规LASIK的临床优势,且均无角膜膨隆征象。
要点
- LASIK Xtra与常规LASIK在12个月随访中未矫正远视力与屈光稳定性无显著差异。
- 两组均未出现角膜膨隆征象,角膜地形图显示角膜曲率稳定。
- 常规LASIK眼在术后1周最佳矫正视力略优于LASIK Xtra眼(P < .05)。
核心结论
- LASIK Xtra看似安全,但相比常规飞秒LASIK无优势。
- 12个月时两组未矫正远视力与屈光稳定性无差异,均无角膜膨隆征象。
研究设计与样本
- 前瞻性、随机、对眼对照临床试验,在德国法兰克福歌德大学眼科开展。
- 纳入26例高度近视和/或近视散光患者,随机一眼行LASIK Xtra(30 mW/cm2,90秒连续紫外线A),另一眼行常规飞秒LASIK。
主要发现
- LASIK Xtra眼未矫正远视力从术前1.26 ± 0.13 logMAR改善至-0.02 ± 0.15 logMAR,常规LASIK眼从1.27 ± 0.12 logMAR改善至0.01 ± 0.15 logMAR(P > .05)。
- LASIK Xtra眼与常规LASIK眼MRSE分别从-7.35 ± 1.15 D和-7.5 ± 1.12 D变化至-0.17 ± 0.43 D和-0.25 ± 0.46 D。
- 12个月随访期间两组结局无显著差异,仅常规LASIK眼在术后1周最佳矫正视力略优(P < .05)。
- 常规LASIK眼术后3至12个月有非显著近视回退趋势,MRSE变化-0.15 D,LASIK Xtra眼为-0.1 D。
- 12个月时角膜地形图显示两组角膜曲率稳定,无角膜膨隆征象。
关键数值与推荐
- LASIK Xtra参数:30 mW/cm2,90秒连续紫外线A照射。
- 主要结局指标包括未矫正远视力、最佳矫正视力、显然验光等效球镜度、内皮细胞计数和角膜厚度。
临床怎么用
- 对于高度近视患者,LASIK Xtra在12个月内未显示优于常规飞秒LASIK的视力或屈光稳定性获益。
- 临床决策时不应仅基于交联的附加作用而常规联合LASIK Xtra,需结合个体风险评估。
局限性
- 样本量较小(26例患者)。
- 随访时间为12个月,长期效果未评估。
- 原文未报告内皮细胞计数和角膜厚度的具体结果数值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the safety and efficacy of femtosecond (fs) laser-assisted in situ keratomileusis (LASIK) combined with accelerated corneal cross-linking (LASIK Xtra) compared to conventional fs-LASIK (convLASIK) in high myopic patients. DESIGN: Prospective, randomized, fellow-eye controlled clinical trial. METHODS: Setting: Department of Ophthalmology, Goethe University, Frankfurt/Germany. StudyPopulation: Twenty-six patients with high myopia and/or myopic astigmatism received randomized treatment with LASIK Xtra (30 mW/cm2, 90 seconds with continuous ultraviolet-A) in 1 eye and convLASIK in the other eye. MainOutcomeMeasures: Uncorrected distance visual acuity (UDVA), best spectacle-corrected VA (BSCVA), manifest refractive spherical equivalent (MRSE), endothelial cell count (ECC), and corneal thickness. RESULTS: The UDVA improved from 1.26 ± 0.13 logMAR preoperative to -0.02 ± 0.15logMAR in LASIK Xtra eyes and from 1.27 ± 0.12 logMAR to 0.01 ± 0.15 logMAR in the convLASIK eyes (P > .05). The MRSE changed from -7.35 ± 1.15 diopters (D) and -7.5 ± 1.12 D to -0.17 ± 0.43 D and -0.25 ± 0.46 D, respectively. There was no significant difference in outcomes between both groups during the 12 months follow-up except for the convLASIK eyes' showing slightly better BSCVA after 1 week (P < .05). ConvLASIK eyes revealed a nonsignificant trend toward myopic regression from 3 to 12 months postoperative with a change in MRSE of -0.15 D compared to -0.1 D in LASIK Xtra eyes. Topography showed stability of corneal curvature with no signs of keratectasia in both groups at 12 months. CONCLUSION: While apparently safe, LASIK Xtra showed no advantages over conventional LASIK. At 12 months, both groups showed no difference regarding UDVA and refractive stability, and no signs of keratectasia.
引用
- Kohnen T, Lwowski C, Hemkeppler E, et al. Comparison of Femto-LASIK With Combined Accelerated Cross-linking to Femto-LASIK in High Myopic Eyes: A Prospective Randomized Trial. Am J Ophthalmol. 2019. PMID: 31678559. doi:10.1016/j.ajo.2019.10.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。